Products |

TeleRehab VersaCare 2.1

Related Content

BioCardia Releases Primary Endpoint Results of Open Label Roll-in Cohort of CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial.
News | Cardiac Rehabilitation
BioCardia Releases Primary Endpoint Results of Open Label Roll-in Cohort of CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial

Sept. 18, 2025 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home September 19, 2025
Home
FDA Expands Use of Repatha
News | Cardiac Rehabilitation
FDA Expands Use of Repatha (evolocumab)

Aug. 25, 2025 — Amgen has announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of ...

Home August 26, 2025
Home
BioCardia CardiAMP
News | Cardiac Rehabilitation
Trial Results Show Autologous Cell Therapy Improves Survival, QOL and Reduces Cardiac Events in Distressed Heart Failure Patients

March 31, 2025 -— BioCardia, Inc. recently announced two-year outcomes from the double-blind randomized placebo ...

Home April 01, 2025
Home
Professor of Biology and Physics Thomas Irving in the lab. Photo courtesy of Illinois Institute of Technology
News | Cardiac Rehabilitation
Illinois Tech Professors’ Paper Challenging Classical View of Muscle Contraction Could Lead to New Cardiac Treatments

February 2, 2023 — In a newly published paper, a team including two professors from Illinois Institute of Technology ...

Home February 02, 2023
Home
3D illustration of an mRNA strand
News | Cardiac Rehabilitation
COVID-19 Vaccine Technique Shows Promise for Heart Disease
May 2, 2022 – A method for delivering genetic material to the body is being tested as a way to repair damaged heart ...
Home May 02, 2022
Home
Lymphatic vessels on the heart
News | Cardiac Rehabilitation
Study Identifies VE-cadherin Protein as Key Factor in Maintenance of Lymphatic Vessels Serving the Heart

February 9, 2022 – Scientists at the UNC School of Medicine led a study to advance the understanding of lymphatic ...

Home February 09, 2022
Home
MedAxiom conducetd a survey of hospitals that offer cardiac rehab, cardiovascular rehabilitation, programs to find out the costs, how they are staffed and how they are implemented.
News | Cardiac Rehabilitation
MedAxiom Survey Highlights Cardiac Rehab Industry Insights and Best Practices

September 14, 2021 – MedAxiom, an American College of Cardiology (ACC) company, released a report detailing cardiac ...

Home September 14, 2021
Home
Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. She was a patient at the DMC Sinai-Grace Hospital in Detroit.
News | Cardiac Rehabilitation
Only 1 in 4 Medicare Patients Participate in Cardiac Rehabilitation

January 15, 2020 – Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a heart ...

Home January 15, 2020
Home
Now cleared by the FDA, PocketECG CRS is a new mobile cardiac rehabilitation system designed to provide high-quality ECG monitoring and automated arrhythmia detection during rehabilitation training. The device monitors a patient's heart rhythm and heart rate to safely guide the intensity and duration of rehabilitation exercises in real-time.
Technology | Cardiac Rehabilitation
FDA Clears PocketECG CRS Mobile Cardiac Rehabilitation System

July 23, 2018 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PocketECG Cardiac ...

Home July 24, 2018
Home
cardiac rehabilitation, depression, death risk, heart surgery, Intermountain Medical Center Heart Institute, AHA Scientific Sessions 2016
News | Cardiac Rehabilitation
Study Finds Cardiovascular Rehab Helps Reduce Death Risk in Depressed Heart Patients

November 15, 2016 — Depression has been known to be associated with poor cardiovascular outcomes. But if patients who ...

Home November 15, 2016
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now